RELIEF THERAPEUTICS Holding AG

RELIEF THERAPEUTICS Holding AG

0QKQ · LSE

0.1398GBP-0.00 (-0.14%)

Price History

Full chart

Market Stats

Previous Close0.14
Open0.1398
Day Range0.1398 – 0.1398
52-Week Range0.14 – 4.50
Volume7
Market Cap172.75M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta-0.33
50-Day Avg1.68
200-Day Avg2.58

About

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

Company Details

Leadership

  • Mr. Zachery W. HendersonCEO & Director · b. 1973
  • Mr. Jeremy Meinen CPAChief Financial Officer · b. 1989
  • Mr. Alexandre CapetChief Operating & Strategy Officer · b. 1973
  • Mr. Frédéric CondoloChief Technology Officer · b. 1973

Financials

Income Statement

Currency: GBP2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.48M14.83M14.54M13.74M386.38K-34.93M20.71M19.49M256.12K15.00K-565.00K--3.32M6.08M6.03M8.42M642.00K
Growth (%)-+497.86%-1.90%-5.53%-97.19%---40.70%-5.91%-98.69%-94.14%-----+83.11%-0.79%+39.52%-92.37%
Cost of Revenue429.86K-----14.79M13.39M12.68M74.00K945.00K3.00K418.00K1.00K-11.91M18.11M1.92M11.12M1.69M
Gross Profit2.05M14.83M14.54M13.74M386.38K-20.14M7.32M6.81M-74.00K-930.00K-3.00K147.00K-1.00K--8.59M-12.03M4.11M-2.70M-1.05M
Gross Margin82.66%100.00%100.00%100.00%100.00%-57.66%35.34%34.93%-28.89%-6200.00%-26.02%---258.54%-197.78%68.18%-32.07%-163.08%
Operating Expense8.19M16.56M23.71M25.85M19.63M-26.32M18.88M18.91M7.00K195.00K1.24M649.00K946.00K-26.62M24.52M114.94M4.97M9.47M
Operating Income-6.14M-1.73M-9.17M-12.11M-19.25M-59.17M-6.18M-11.56M-12.10M-81.00K-1.13M-1.25M-502.00K-947.00K-19.30M-35.21M-36.55M-110.83M-7.67M-10.52M
Operating Margin-247.70%-11.69%-63.04%-88.12%-4981.60%--17.69%-55.80%-62.10%-31.63%-7500.00%--88.85%---1060.22%-601.00%-1837.03%-91.11%-1637.85%
EBITDA-5.57M2.27M-4.98M-8.19M-15.38M-57.13M478.10K-9.88M-6.02M-81.00K-16.48M-1.79M-483.00K-12.02M-6.09M-33.22M-50.26M-108.20M-16.73M-8.88M
EBITDA Margin-224.76%15.31%-34.22%-59.60%-3980.78%-1.37%-47.69%-30.90%-31.63%-109866.67%--85.49%---1000.33%-826.51%-1793.50%-198.72%-1382.71%
Net Income-7.22M-2.00M-9.40M-12.21M-19.40M-59.17M-1.30M-12.24M-12.40M-81.00K-16.83M-2.89M-436.00K-7.46M-7.83M-34.70M-50.79M-98.18M-17.12M-9.91M
Net Income Margin-291.33%-13.49%-64.63%-88.89%-5020.16%--3.71%-59.09%-63.63%-31.63%-112226.67%--77.17%---1045.02%-835.22%-1627.40%-203.39%-1542.99%
R&D4.68M11.29M20.17M20.15M14.55M54.70M1.90M-------13.64M19.02M12.39M91.21M1.36M5.29M
R&D as % of Total Revenue188.59%76.15%138.69%146.62%3765.19%-5.45%--------572.84%203.80%1511.79%16.12%823.83%
Interest Expense1.01M654.48K779.91K325.52K401.01K330.50K724.25K627.70K491.79K134.54K324.00K107.00K144.00K138.00K169.00K268.00K196.00K164.00K69.00K281.00K
Interest Expense % of Total Revenue40.65%4.41%5.36%2.37%103.79%-2.07%3.03%2.52%52.53%2160.00%-25.49%--8.07%3.22%2.72%0.82%43.77%

Balance Sheet

Currency: GBP2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets76.76M79.13M76.66M65.22M58.30M3.28M1.29M45.98M41.62M13.00K31.42M30.97M35.58M19.86M78.05M251.62M188.80M76.39M53.22M51.53M
Total Liabilities10.63M14.63M7.73M8.49M5.93M2.81M3.97M25.37M15.27M66.00K9.19M10.03M14.29M5.57M11.00M70.09M43.38M24.16M16.56M13.19M
Total Equity66.13M64.50M68.94M56.73M52.38M464.04K-2.69M20.15M26.36M-53.00K22.24M20.95M21.28M14.30M67.04M181.53M145.42M52.23M36.66M38.34M
Cash1.16M11.01M14.09M4.63M2.40M1.80M333.92K947.30K5.01M13.00K394.00K135.00K265.00K129.00K43.15M44.76M19.24M14.56M15.08M9.47M
Total Debt86.91K3.77M515.95K331.25K393.53K752.61K2.74M8.45M3.90M4.60M878.00K1.01M1.05M1.74M891.00K4.26M4.34M4.31M2.14M1.81M
Net Debt-1.07M-7.24M-13.57M-4.30M-2.00M-1.05M2.41M7.51M-1.11M-13.00K484.00K877.00K788.00K1.61M-42.26M-40.50M-14.89M-10.24M-12.94M-7.67M

Cash Flow

Currency: GBP2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.28M-3.73M-9.55M-3.32M-16.44M-10.24M-4.65M-8.76M-8.73M-27.00K-2.89M-1.17M-618.00K-748.00K-18.23M-35.71M-24.11M-17.61M-2.73M-6.90M
Investing Cash Flow-481.66K388.27K-734.05K-5.76M-469.55K2.69M9.58K-962.00K-585.58K-474.08K125.00K3.00M3.00M3.00M3.00M-30.27M-8.02M8.70M4.21M3.33M
Financing Cash Flow13.04M-965.42K13.38M-380.56K14.59M6.94M3.17M9.75M13.41M2.27M3.14M914.00K748.00K620.00K58.18M67.69M6.42M4.05M-862.00K13.01M
Capital Expenditure474.60K300.82K824.86K5.77M475.98K13.92K2.91K898.28K874.17K474.08K11.00K000013.71M521.00K446.00K14.00K6.24M
Free Cash Flow1.81M-4.03M-10.38M-9.09M-16.92M-10.26M-4.65M-9.66M-9.61M-501.08K-2.90M-1.17M-618.00K-748.00K-18.23M-49.42M-24.63M-18.06M-2.74M-13.13M
Dividends Paid--------------58.20M67.69M6.81M---
FCF to OCF79.22%108.06%108.63%274.13%102.89%100.14%100.06%110.25%110.01%1855.87%100.38%100.00%100.00%100.00%100.00%138.39%102.16%102.53%100.51%190.46%
Dividend Paid to FCF---------------319.18%-136.97%-27.64%---

Earnings

Report DateApr 30, 2024Apr 10, 2025Aug 28, 2025
EPS Estimate0.000.00-
EPS Actual-3.36-0.50-0.36
Surprise---
Timing--Pre-market

Key Statistics & Ratios

Market Cap172.75M
Enterprise Value20.03M
Trailing P/E0.00
Forward P/E0.00
Price / Sales431.60
Price / Book0.00
EPS-0.01
Book Value0.211
Revenue (TTM)1.20M
Gross Profit (TTM)1.08M
EBITDA-10.21M
Profit Margin0.00%
Operating Margin-1144.71%
Return on Equity-51.56%
Return on Assets-25.46%
Shares Outstanding633.95M
Shares Float51.11M
Beta-0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 5, 20231:400